Integrin αIIbβ3
Anti-Integrin αIIbβ3 Recombinant Antibody Products
-
- Derivation: Human
- Species Reactivity: Human
- Type: Antibody
Compare
-
- Derivation: Phage display library
- Type: Human antibody
- Application: ELISA, FC, Inhib
Compare
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, FC
Compare
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, FC
Compare
-
- Derivation: Phage display library
- Type: Human antibody
- Application: ELISA, FC
Compare
-
- Derivation: Phage display library
- Type: Human antibody
- Application: ELISA, FC
Compare
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, FC
Compare
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, FC
Compare
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, FC
Compare
-
- Species Reactivity: Human
- Type: Human IgG
- Application: FC, FuncS
Compare
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, FC
Compare
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, FC
Compare
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, FC
Compare
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, FC
Compare
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, FC
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA, FC
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA, FC
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA, FC
Compare
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA, FC
Compare
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, FC
Compare
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: ELISA, FC
Compare
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: ELISA, FC
Compare
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: ELISA, FC
Compare
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: ELISA
Compare
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: ELISA
Compare
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: ELISA, FC, Inhib
Compare
More Infomation
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
In medicine, glycoprotein IIb/IIIa (GPIIb/IIIa, also known as integrin αIIbβ3) is an integrin complex found on platelets. It is a receptor for fibrinogen and von Willebrand factor and aids platelet activation. The complex is formed via calcium-dependent association of gpIIb and gpIIIa, a required step in normal platelet aggregation and endothelial adherence. Platelet activation by ADP (blocked by clopidogrel) leads to the aforementioned conformational change in platelet gpIIb/IIIa receptors that induces binding to fibrinogen. The gpIIb/IIIa receptor is a target of several drugs including abciximab, eptifibatide, tirofiban.
In medicine, glycoprotein IIb/IIIa (GPIIb/IIIa, also known as integrin αIIbβ3) is an integrin complex found on platelets. It is a receptor for fibrinogen and von Willebrand factor and aids platelet activation. The complex is formed via calcium-dependent association of gpIIb and gpIIIa, a required step in normal platelet aggregation and endothelial adherence. Platelet activation by ADP (blocked by clopidogrel) leads to the aforementioned conformational change in platelet gpIIb/IIIa receptors that induces binding to fibrinogen
The integrin αIIbβ3 specific antibodies are used for treatment to prevent thrombosis in conditions selected from the group consisting of pulmonary embolism, transient ischemic attacks (TIAs), deep vein thrombosis, coronary bypass surgery, and surgery to insert a prosthetic valve or vessel in autologous, non-autologous, or synthetic vessel graft. A further embodiment contemplates using the antibody that specifically immunoreacts with integrin αIIBβ3 as a medicament for treatment to prevent thrombosis.